World Academy of Science, Engineering and Technology
Published November 4, 2014 | Version 9999951
Journal article Open

The Antibacterial and Anticancer Activity of Marine Actinomycete Strain HP411 Isolated in the Northern Coast of Vietnam

Creators

Description

Since the marine environmental conditions are
extremely different from the other ones, marine actinomycetes might
produce novel bioactive compounds. Therefore, actinomycete strains
were screened from marine water and sediment samples collected
from the coastal areas of Northern Vietnam. Ninety-nine
actinomycete strains were obtained on starch-casein agar media by
dilution technique, only seven strains, named HP112, HP12, HP411,
HPN11, HP 11, HPT13 and HPX12, showed significant antibacterial
activity against both gram-positive and gram-negative bacteria
(Bacillus subtilis ATCC 6633, Staphylococcus epidemidis ATCC
12228, Escherichia coli ATCC 11105). Further studies were carried
out with the most active HP411 strain against Candida albicans
ATCC 10231. This strain could grow rapidly on starch casein agar
and other media with high salt containing 7-10% NaCl at 28-30oC.
Spore-chain of HP411 showed an elongated and circular shape with
10 to 30 spores/chain. Identification of the strain was carried out by
employing the taxonomical studies including the 16S rRNA
sequence. Based on phylogenetic and phenotypic evidence it is
proposed that HP411 to be belongs to species Streptomyces
variabilis. The potent of the crude extract of fermentation broth of
HP411 that are effective against wide range of pathogens: both grampositive,
gram-negative and fungi. Further studies revealed that the
crude extract HP411 could obtain the anticancer activity for cancer
cell lines: Hep-G2 (liver cancer cell line); RD (cardiac and skeletal
muscle letters cell line); FL (membrane of the uterus cancer cell line).
However, the actinomycetes from marine ecosystem will be useful
for the discovery of new drugs in the future.

Files

9999951.pdf

Files (345.4 kB)

Name Size Download all
md5:94aba7f286cc3de05e3c3eb1217095d0
345.4 kB Preview Download

Additional details

References

  • A. L. Demain, S. Sánchez S, "Microbial drug discovery: 80 years of progress", J. Antibiot. vol. 62, pp 5-16, 2009.
  • J. Berdy, "Bioactive microbial metabolites", J. Antibiotechnol. (Tokyo), vol. 58, pp. 1-26, 2005.
  • N. S. Egorov, O. Z. Popova, M. V. Bitteeva, V. G. Bulgakova, K. Gofman "Influence of bacterial metabolites on growth and antibiotic properities of some actinomycetes", Mikrobiologia, vol. 29, pp. 269- 275, 1960 (in Russian)
  • H. P. Fiedler, B. Christina, T. B. Alan, C. W. Alan, G. Michael, P. Olivier, P. Carsten, H. Gerhard, H, "Marine Actinomycetes as a source of novel secondary metabolites", Antonie Leeuwenhock, vol. 87, pp. 37- 42, 2005.
  • B. N. Ghanem, A. S. Soraya, M. E. Zeinab, A. A. E. Gehan, "Isolation and enumeration of marine Actinomycetes from seawater and sediments in Alexandria", J. Gen. Appl. Microbiol, vol. 46(45), pp. 105-111, 2000.
  • H. Harada, Y. Kamei, "Selective cytotoxicity of marine algae extracts to several human leukemic cell lines", Cytotechnology, vol. 25, pp. 213–219, 1997.
  • M. Jennifer, "Determination of minimum inhibitory concentration", J. Antinicrobial Chemotherapy, vol. 48, Suppl. S1, pp. 5-16, 2001.
  • M. Kimura, "A Simple Method for Estimating Evolutionary Rates of Base Substitutions Through Comparative Studies of Nucleotide Sequences", J. Molecular Evolution, vol. 16, pp. 111-120, 1980.
  • K. S. Lam, "Discovery of novel metabolites from marine actinomycetes", Curr Opin Microbiol., vol. 12, pp. 245–251, 2006. [10] K. Likhitwitayawuid, C. K. Angerhofer, G. A. Cordell, J. M. Pezzuto, N. Ruangrungsri, "Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania erecta", J. Natural Products, vol. 56, pp. 30- 38, 1993. [11] T. J. Mincer, P. R. Jensen, C. A. Kauffman, W. Fenical, "Widespread and persistent populations of a major new marine actinomycte taxon in ocean sediments", J. Appl. Environ. Microbiol., vol. 68, pp. 2005-5011, 2002. [12] G. Mohanraj, T. Sekar, "Antagonistic activity of marine Streptomyces sp LCJ94 against the shrimp pathogens", Annals of Biological Research, vol. 4 (4), pp. 224-227, 2013. [13] T. F. Molinski, D. S. Dalisay, S. L. Lievens, "Drug development from marine natural products", Nat Rev Drug Discov, vol. 8, pp. 69-85, 2009. [14] K. Moller, T. K. Jensen, S. E. Jorsal, T. D. Leser, B. Cartensen, Veterinary Microbiology, vol. 62, pp. 59–72, 1998. [15] M. Nakagawas, Y. Hayakawa, K. Adachi, H. Seto, "A new depsipeptide antibiotic, variapeptin" Agric. Biol. Chem., vol. 54(3), pp. 791-794, 1990. [16] D. J. Newman, G. M. Cragg, "Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010", J. Nat. Prod., vol. 75(3), pp. 311–335, 2012. [17] C. Olano, C. Méndez, J. A. Salas, "Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis", J. Nat. Prod. Rep., vol. 26, pp. 628–660, 2009. [18] N. Saitou, M. Nei, "The Neighbor-joining Method: A New Method for Reconstructing Phylogenetic Trees, Mol. Biol. Evol., 4: 406-425, 1987. [19] E. B. Shirling, D. Gottlieb, "Methods for Characterization of Streptomyces species" Intern. J. Systematic Bacteriology, vol. 16 (3), pp. 313-340, 1966. [20] H. D. Tresner, E. J. Backus, "System of color whells for Streptomycete taxonomy" Appl. Microbiol., vol. 11, pp. 335-338, 1963. [21] S. T. Williams, M. Goodfellow, G. Alderson, "Genus Streptomyces". In: Bergey's Manual of Systematic Bacteriology, (S.T. Williams; M. E. Sharpe; J. Holt, Edts.) Baltimore, Williams and Wilkins. vol. 4, pp. 2452-2468, 1989.